| Announce Date | 02/05/2026 |
| EPS Normalized Actual | $3.42 (Beat by $0.03) |
| EPS GAAP Actual | $3.42 (Beat by $0.03) |
| Revenue Actual | $4.364B |
| Revenue Surprise | Beat by $4364M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 18.305 | 9.95 | 17.84305 | 18.82986 | 2 |
| Dec 2028 | 18.845 | 9.67 | 18.56235 | 19.12468 | 6 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 3.02 | 3.02 | 4.364B | 9.3% | 4364M |
| FQ3 2025 (Sep 2025) | 1.94 | 1.94 | 4.1B | 4.98% | 4100M |
| FQ2 2025 (Jun 2025) | 1.55 | 1.55 | 4.017B | 5.05% | 4017M |
| FQ1 2025 (Mar 2025) | 1.42 | 1.42 | 3.829B | 2.4% | 3829M |
| FQ4 2024 (Dec 2024) | 2.44 | 2.44 | 3.958B | 2.27% | 3958M |
| FQ3 2024 (Sep 2024) | 1.57 | 1.57 | 3.896B | 4.11% | 3896M |
| FQ2 2024 (Jun 2024) | 1.99 | 1.99 | 3.814B | 2.25% | 3814M |
| FQ1 2024 (Mar 2024) | 1.58 | 1.58 | 3.737B | 100% | 3737M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 5.27 | -- | 5.16419 | 5.36168 | 3 |
| FQ3 2029 (Sep 2029) | 4.87 | -- | 4.77222 | 4.95472 | 6 |
| FQ2 2029 (Jun 2029) | 4.47 | -- | 4.38025 | 4.54776 | 3 |
| FQ1 2029 (Mar 2029) | 4.25 | -- | 4.16467 | 4.32393 | 3 |
| FQ4 2028 (Dec 2028) | 4.55 | -- | 4.45864 | 4.62915 | 4 |
| FQ3 2028 (Sep 2028) | 4.19 | -- | 4.10587 | 4.26289 | 6 |
| FQ2 2028 (Jun 2028) | 3.84 | -- | 3.7629 | 3.9068 | 4 |
| FQ1 2028 (Mar 2028) | 3.64 | -- | 3.55757 | 3.6993 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Dec 2029) | 5.01B | -- | 4.93B | 5.08B | 6 |
| FQ3 2029 (Sep 2029) | 4.86B | -- | 4.79B | 4.93B | 4 |
| FQ2 2029 (Jun 2029) | 4.8B | -- | 4.73B | 4.87B | 6 |
| FQ1 2029 (Mar 2029) | 4.66B | -- | 4.59B | 4.73B | 4 |
| FQ4 2028 (Dec 2028) | 4.72B | -- | 4.64B | 4.78B | 5 |
| FQ3 2028 (Sep 2028) | 4.58B | -- | 4.51B | 4.64B | 3 |
| FQ2 2028 (Jun 2028) | 4.52B | -- | 4.45B | 4.58B | 5 |
| FQ1 2028 (Mar 2028) | 4.39B | -- | 4.32B | 4.45B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 3.02 | 3.02 | 100% | |
| FQ3 2025 (Sep 2025) | 1.94 | 1.94 | 100% | |
| FQ2 2025 (Jun 2025) | 1.55 | 1.55 | 100% | |
| FQ1 2025 (Mar 2025) | 1.42 | 1.42 | 100% | |
| FQ4 2024 (Dec 2024) | 2.44 | 2.44 | 100% | |
| FQ3 2024 (Sep 2024) | 1.57 | 1.57 | 100% | |
| FQ2 2024 (Jun 2024) | 1.99 | 1.99 | 100% | |
| FQ1 2024 (Mar 2024) | 1.58 | 1.58 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $4.36B | $4364M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $4.1B | $4100M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $4.02B | $4017M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $3.83B | $3829M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.96B | $3958M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.9B | $3896M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.81B | $3814M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.74B | $3737M | 100% |